Remove Documentation Remove Information Remove Medical Records
article thumbnail

How blockchain can revolutionise medical records and save lives

pharmaphorum

If appropriately implemented, blockchain-based medical records systems of tomorrow could be far more accurate, secure and accessible than the one-size-fits-all approach applied to today’s electronic health records, all while putting additional power back in the hands of the patients. The state of medical records today.

article thumbnail

Medical Documentation

RX Note

Introduction Medical/health records form an essential part of a patient’s present and future health care. As a written collection of information about a patient's health and treatment, they are used essentially for the present and continuing care of the patient. Include any discussion of the issue with medical or nursing staff.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UK gov’t defends NHS data sharing plans in strategy document

pharmaphorum

The UK’s Department of Health and Social Care has published a document setting out its strategy on handling patient data – and defending its plan to transfer millions of GP records into a centralised database. The post UK gov’t defends NHS data sharing plans in strategy document appeared first on.

article thumbnail

Investigation launched into alleged animal welfare violations at Neuralink

pharmaphorum

Reuters said it has interviewed 20 current and former Neuralink employees in its investigation, as well as reviewing internal company documents. We only know Animal 20’s story because we sued @UCDavis for the medical records & are still engaged in a lawsuit to get access to photos and videos of these experiments.

article thumbnail

NHS data sharing scheme “on hold” as millions opt out

pharmaphorum

The centralised database of medical records from 55 million people was first unveiled in May and due to come online on 1 July, but had its start date pushed back to 1 September after campaigners pushed back against the proposals. million in June – and a drive should be carried out to raise awareness of the scheme.

article thumbnail

Lots of FDA Guidance, But Few Drug Manufacturing “Remote Interactive Evaluations” (We Would Call Them “Virtual Inspections”)

FDA Law Blog: Biosimilars

A phone call to FDA requested information about the number of Remote Interactive Evaluations (RIEs) that FDA has performed at drug manufacturing facilities since it announced in April 2021 that it would start using them as an alternative to on-site inspections. We should explain what RIEs are.

article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law Blog: Biosimilars

FDA recognizes the potential of RWE to support regulatory submissions of medical devices and to inform benefit-risk analysis of such products, while assuring patients have timely access to devices. Rather than looking at how RWD/RWE provide meaningful information on safety and effectiveness, reviewers often focus on perceived gaps.